Different doses of dexmedetomidine on respiration in patients with non-invasive respiratory monitoring system

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039009

Enrollment

Unknown

Registered

2020-10-13

Start date

2020-11-01

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of different doses of dexmedetomidine on respiration

Interventions

Experimental groups:0.5ug/kg.10min dexmedetomidine

control groups:1.0ug/kg.10min dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Hospitalization for elective general anesthesia; 2. Aged 70 years and above.

Exclusion criteria

Exclusion criteria: 1. Allergic to dexmedetomidine; 2. Pregnant and lactating women; 3. Heart failure, respiratory failure; 4. Bradycardia,liver and kidney dysfunction; 5. Refused to participate.

Design outcomes

Primary

Measure	Time frame
Vital signs;	—

Countries

China

Contacts

Public ContactZheng Zhenzhen

Qilu Hospital, Shandong University

zhengzz9102@163.com+86 18353681529

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026